GSK-Pfizer consumer healthcare joint venture

Haleon is a leading independent consumer healthcare company, formed through the combination of the consumer health portfolios of GSK and Pfizer and its subsequent demerger in 2022. The company possesses a diverse portfolio of world-class brands including Sensodyne, Advil, Voltaren, Panadol, and Centrum, which are trusted by millions of consumers globally. Haleon operates across five key categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements. By integrating scientific expertise with consumer insights, the company aims to deliver innovative solutions for everyday health needs. Haleon is listed on both the London and New York stock exchanges and maintains a significant global footprint in over 100 countries.